| Treatment outcome, n (%) |  | ||||
---|---|---|---|---|---|---|
Variable | Cured | Treatment Completed | Defaulted | Failed treatment | Died | Transferred out |
Treatment outcome rate (%), n = 2262 | 53.5 | 25.6 | 10.6 | 2.4 | 7.8 |  |
Age (year) | ||||||
 18–34 | 619 (51.1) | 210 (36.2) | 128 (53.3) | 21 (38.9) | 51 (28.8) | 66 (51.9) |
 35–54 | 469 (38.7) | 272 (46.9) | 83 (35.6) | 26 (48.1) | 85 (48.0) | 43 (33.9) |
  ≥ 55 | 123 (10.2) | 98 (16.9) | 29 (12.1) | 7 (13.0) | 41 (23.2) | 18 (14.2) |
 Total | 1211 (100.0) | 580 (100.0) | 240 (100.0) | 54 (100.0) | 177 (100.0) | 127 (100.0) |
Sex | ||||||
 Male | 724 (59.9) | 304 (52.4) | 160 (66.7) | 35 (66.8) | 111 (62.7) | 72 (56.7) |
 Female | 487 (40.2) | 276 (47.6) | 80 (33.3) | 19 (35.2) | 66 (37.3) | 55 (43.3) |
 Total | 1211 (100,0) | 580 (100.0) | 240 (100.0) | 54 (100.0) | 177 (100.0) | 127 (100.0) |
HIV status (n = 2117) | ||||||
 Positive | 129 (11.5) | 171 (30.4) | 67 (30.5) | 9 (18.0) | 51 (31.9) | 28 (27.2) |
 Negative | 995 (88.5) | 392 (69.6) | 153 (69.5) | 41 (82.0) | 109 (68.1) | 75 (72.8) |
 Total | 1124 (100.0) | 563 (100.0) | 220 (100.0) | 50 (100.0) | 160 (100.0) | 103 (100.0) |
DOT clinic attended | ||||||
 UCH | 251 (20.7) | 389 (67.1) | 115 (47.9) | 18 (33.3) | 86 (48.6) | 75 (59.1) |
 GCHJ | 960 (79.3) | 191 (32.9) | 125 (52.1) | 36 (65.7) | 91 (51.4) | 52 (40.9) |
 Total | 1211 (100.0) | 580 (100.0) | 240 (100.0) | 54 (100.0) | 177 (100.0) | 127 (100.0) |
Year of enrolment | ||||||
 2013 | 207 (17.1) | 118 (20.3) | 33 (13.3) | 7 (13.0) | 32 (18.1) | 34 (26.8) |
 2014 | 286 (23.6) | 104 (17.9) | 56 (23.3) | 9 (16.7) | 38 (21.5) | 30 (23.6) |
 2015 | 197 (16.3) | 93 (16.0) | 39 (16.2) | 8 (14.8) | 28 (15.8) | 28 (22.0) |
 2016 | 285 (23.5) | 98 (16.9) | 52 (21.7) | 10 (18.5) | 41 (23.2) | 30 (23.6) |
 2017 | 236 (19.5) | 167 (28.8) | 60 (25.0) | 20 (37.0) | 38 (21.5) | 5 (3.9) |
 Total | 1211 (100.0) | 580 (100.0) | 240 (100.0) | 54 (100.0) | 177 (100.0) | 127 (100.0) |